Loading candles…
Novelix Pharmaceuticals Ltd, incorporated in 1994 and headquartered in Hyderabad, operates in the pharmaceuticals and life sciences industries in India. Formerly known as Trimurthi Limited, the company underwent a strategic pivot and rebranding in late 2024 to concentrate exclusively on life sciences and pharmaceutical research sectors. Its business segments include the research, development, manufacturing, and trading of Active Pharmaceutical Ingredients (APIs), bulk drugs, pharmaceutical intermediates, key starting materials, and pharmaceutical-related products and securities. While the company does not have publicly disclosed founders, key management, subsidiaries, or listing exchanges, it maintains a presence through its varied pharmaceutical product offerings and trading activities.
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.